These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 2027866)

  • 1. [HLA antigens in diffuse toxic goiter].
    Dedov II; Polozkova NI; Polianskaia IS; Efuni SS
    Probl Endokrinol (Mosk); 1991; 37(1):4-5. PubMed ID: 2027866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of the frequency of HLA antigens in diffuse toxic goiter and autoimmune thyroiditis].
    Rasovskiĭ BL; Kiseleva TP; Kustova NI; Akhmed'ianova LG; Minina VM
    Probl Endokrinol (Mosk); 1987; 33(1):15-8. PubMed ID: 3823016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The HLA system in diffuse toxic goiter].
    Rasovskiĭ BL; Kustova NI; Akhmed'ianova LG; Minina VM
    Probl Endokrinol (Mosk); 1990; 36(3):3-6. PubMed ID: 2395829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A,B,C and DR antigens in Chinese with non-insulin-dependent diabetes: comparison with goitrous diabetics.
    Huang HS; Huang MJ; Huang CC; Huang BY; Lin JD; Juang JH; Liu RT
    Taiwan Yi Xue Hui Za Zhi; 1989 Jan; 88(1):43-7. PubMed ID: 2754419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical peculiarities of diffuse toxic goiter in males].
    Romanchishen AF; Volert VA
    Vestn Khir Im I I Grek; 2005; 164(6):43-7. PubMed ID: 16792314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Goitrous Hashimoto's thyroiditis. Lack of association with HLA antigens.
    Fein HG; Metz S; Nikolai TF; Johnson AH; Smallridge RC
    Mol Biol Med; 1986 Apr; 3(2):195-9. PubMed ID: 3461235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [HLA haplotypes and the predisposition to diffuse toxic goiter].
    Kamynina TS; Manishkina VP; Stepanova EB
    Ter Arkh; 1994; 66(12):80-3. PubMed ID: 7900056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relative number of B-lymphocytes in endocrine opthalmopathy in patients with diffuse toxic goiter].
    Kazanavichius GV; Danis IuK
    Probl Endokrinol (Mosk); 1991; 37(5):29-30. PubMed ID: 1780283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA antigens and diffuse toxic goiter in Taiwan.
    Chen FW; Chen YC; Deng JS; Chen TS; Chen GH
    Taiwan Yi Xue Hui Za Zhi; 1978 Jan; 77(1):77-83. PubMed ID: 274517
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunological reactivity and the HLA system antigens in patients with autoimmune thyroiditis and nodular euthyroid goiter].
    Privalov VA; Vasil'ev SA
    Probl Endokrinol (Mosk); 1989; 35(4):22-7. PubMed ID: 2602347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interactions between serum antibodies of patients with autoimmune thyropathies and isolated cells of diffuse toxic euthyroid nodular goiter].
    Kraĭnova SI; Kandror VI
    Probl Endokrinol (Mosk); 1993; 39(6):46-50. PubMed ID: 8290513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individual immunogenetic characterization of patients with diffuse toxic goiter and autoimmune thyroiditis].
    Rasovskiĭ BL; Kiseleva TP; Kustova NI; Akhmed'ianova LG; Matiunin DG
    Probl Endokrinol (Mosk); 1991; 37(3):15-7. PubMed ID: 1946283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-cell immunity and immunomodulators in the comprehensive treatment of diffuse toxic goiter].
    Petunina NA; Balabolkin MI; Arion VIa
    Ross Med Zh; 1992; (5-12):19-24. PubMed ID: 1286263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
    Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
    J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibodies to the plasma membranes of thyrocytes in patients with diffuse toxic goiter during treatment with mercazole].
    Saarma VA; Podar TU
    Probl Endokrinol (Mosk); 1988; 34(5):17-9. PubMed ID: 3217382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Association of antigens of the HLA system and Hashimoto's thyroiditis].
    Bazarova EN; Efuni SS; Polianskaia IS; Fedoseeva GI; Okeanova TA
    Probl Endokrinol (Mosk); 1988; 34(5):14-6. PubMed ID: 3217381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predicting the recurrence of thyrotoxicosis after iodine radioisotope therapy of diffuse toxic goiter].
    Ametov AS; Livshits AKh; Oleĭnik EK
    Probl Endokrinol (Mosk); 1988; 34(1):13-6. PubMed ID: 3362805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HLA class I and II antigens and diffuse toxic goiter].
    Kalinin AP; Kamynina TS; Zaretskaia IuM; Abramov VIu; Klinova EG; Karachintsev VI
    Ter Arkh; 1993; 65(3):81-5. PubMed ID: 8059394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The clinical laboratory manifestations of severe form of diffuse toxic goiter].
    Farkhutdinova LM; Allaberdina DU; Gaĭsarova GA; Biglova GA; Kruglova OI; Guseva PS; Mazherina LIa; Khamitov AA; Kashaev MSh; Poliakov IV; Bakiev IM
    Klin Lab Diagn; 2012 Apr; (4):44-6. PubMed ID: 22768719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Acid phosphatase of leukocytes in patients with diffuse toxic goiter in evaluating the stage of the disease].
    Vaiuta NP; Livshits AKh; Mendeleev IM
    Ter Arkh; 1987; 59(6):104-6. PubMed ID: 3629485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.